Shortcast: Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB
About this episode
Dr. Mark Wijnen discusses two cases of Teriparatide treatment in patients with Mucopolysaccharidosis Type IVB and the associated cardiac risks.
In this Shortcast Dr Mark Wijnen presents two cases where Teriparatide was used to treat bone complications in MPD IVB but explains how temporally associated cardiac disease compels his groups to advise caution in its use. Teriparatide in Two Patients With Mucopolysaccharidosis Type IVB Mark Wijnen, Evert F. S. van Velsen, J. Gert-Jan Milhous, Esmee Oussoren, Bram C. J. van der Eerden, Margreet A. E. M. Wagenmakers First published: 13 April 2026 https://doi.org/10.1002/jmd2.70088
More episodes of JIMD Podcasts
- Hidden Disease or Uncertain Risk? Rethinking IMD Diagnosis and Newborn Screening
- IMD Research Round-Up: Phenylketonuria
- Rapamycin and Pharmacogenomics in Niemann-Pick C
- Shortcast: Clinical Outcomes in Hydroxocobalamin-Treated Patients With Early-Onset Cobalamin C Disease
- Feeding the Microbiome: Rethinking Protein and Propionate in MMA
Explore listener stats, chart rankings, contacts and more on the JIMD Podcasts podcast page.